Cencora, Inc. (NYSE: COR) announces it has entered into a definitive agreement to acquire the majority of the outstanding equity interests that it does not currently own in OneOncology, a physician-led national platform empowering independent medical specialty practices rooted in oncology, from TPG, a leading global alternative asset management firm. The transaction values the OneOncology enterprise at $7.4 billion, with an equity value of approximately $6 billion. Cencora will acquire the majority of the outstanding equity interests it does not own in OneOncology from TPG and other shareholders for approximately $3.6 billion and retire its existing corporate debt of $1.3 billion, for a total cash consideration of approximately $5.0 billion.
Read the full article: Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology //
Source: https://www.businesswire.com/news/home/20251214817301/en/Cencora-Accelerates-OneOncology-Acquisition-Extending-Solutions-Offering-for-Community-Oncology